165 related articles for article (PubMed ID: 1526086)
1. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
Simpson GM; Gratz SS
Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
[TBL] [Abstract][Full Text] [Related]
2. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
Cusson JR; Goldenberg E; Larochelle P
J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
[TBL] [Abstract][Full Text] [Related]
3. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
[TBL] [Abstract][Full Text] [Related]
4. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Dingemanse J; Hussain Y; Korn A
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
[TBL] [Abstract][Full Text] [Related]
5. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
[TBL] [Abstract][Full Text] [Related]
6. Interaction between moclobemide and oral tyramine in depressed patients.
Burgess CD; Mellsop GW
Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
[TBL] [Abstract][Full Text] [Related]
8. Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors.
Bieck PR; Antonin KH
J Neural Transm Suppl; 1989; 28():21-31. PubMed ID: 2794993
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
Da Prada M; Burkard WP
Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
[TBL] [Abstract][Full Text] [Related]
11. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
Bieck PR
Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
[TBL] [Abstract][Full Text] [Related]
12. Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.
Gieschke R; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1988; 26():97-104. PubMed ID: 3283292
[TBL] [Abstract][Full Text] [Related]
13. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
[TBL] [Abstract][Full Text] [Related]
14. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.
Antal EJ; Hendershot PE; Batts DH; Sheu WP; Hopkins NK; Donaldson KM
J Clin Pharmacol; 2001 May; 41(5):552-62. PubMed ID: 11361052
[TBL] [Abstract][Full Text] [Related]
15. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
16. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
Da Prada M; Kettler R; Burkard WP; Lorez HP; Haefely W
Acta Psychiatr Scand Suppl; 1990; 360():7-12. PubMed ID: 2248079
[TBL] [Abstract][Full Text] [Related]
17. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
Tiller JW; Maguire KP; Davies BM
Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
[TBL] [Abstract][Full Text] [Related]
18. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes.
Coupland NJ; Wilson SJ; Potokar JP; Bell CE; Bailey JE; Nutt DJ
Int Clin Psychopharmacol; 1995 Nov; 10(4):229-38. PubMed ID: 8748044
[TBL] [Abstract][Full Text] [Related]
20. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
Burkard W; d'Agostini F; Kettler R; Da Prada M
Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
